Amol D. Kulkarni

512 total citations
21 papers, 387 citations indexed

About

Amol D. Kulkarni is a scholar working on Ophthalmology, Radiology, Nuclear Medicine and Imaging and Molecular Biology. According to data from OpenAlex, Amol D. Kulkarni has authored 21 papers receiving a total of 387 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Ophthalmology, 8 papers in Radiology, Nuclear Medicine and Imaging and 6 papers in Molecular Biology. Recurrent topics in Amol D. Kulkarni's work include Retinal Diseases and Treatments (7 papers), Retinal Development and Disorders (4 papers) and Retinal and Macular Surgery (3 papers). Amol D. Kulkarni is often cited by papers focused on Retinal Diseases and Treatments (7 papers), Retinal Development and Disorders (4 papers) and Retinal and Macular Surgery (3 papers). Amol D. Kulkarni collaborates with scholars based in United States, India and Rwanda. Amol D. Kulkarni's co-authors include Daniel M. Albert, Paul R. van Ginkel, Mary J. Lindstrom, Soesiawati R. Darjatmoko, Lalita Subramanian, Arthur S. Polans, Dhruv Sareen, Michael S. Ip, Baruch D. Kuppermann and Radouil Tzekov and has published in prestigious journals such as Clinical Cancer Research, Ophthalmology and Investigative Ophthalmology & Visual Science.

In The Last Decade

Amol D. Kulkarni

21 papers receiving 378 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Amol D. Kulkarni United States 9 165 120 76 65 46 21 387
Yingjie Ma China 12 69 0.4× 58 0.5× 10 0.1× 18 0.3× 28 0.6× 30 304
Dan-dan Zhou China 12 57 0.3× 248 2.1× 7 0.1× 76 1.2× 33 0.7× 24 445
Shaopin Zhu China 10 136 0.8× 106 0.9× 8 0.1× 79 1.2× 53 1.2× 17 282
Masahiko Kure Japan 7 68 0.4× 112 0.9× 3 0.0× 42 0.6× 30 0.7× 10 315
Fen Xiong China 12 92 0.6× 262 2.2× 2 0.0× 84 1.3× 105 2.3× 26 521
Lian Wang China 10 7 0.0× 376 3.1× 18 0.2× 13 0.2× 34 0.7× 33 668
Jingxue Ma China 12 248 1.5× 109 0.9× 213 3.3× 109 2.4× 45 418
Giulia Lavinia Fonti Italy 8 13 0.1× 74 0.6× 3 0.0× 12 0.2× 19 0.4× 12 339
Yotaro Matsuoka Japan 11 245 1.5× 56 0.5× 144 2.2× 20 0.4× 23 369
Peter DeBry United States 6 337 2.0× 76 0.6× 209 3.2× 17 0.4× 11 490

Countries citing papers authored by Amol D. Kulkarni

Since Specialization
Citations

This map shows the geographic impact of Amol D. Kulkarni's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Amol D. Kulkarni with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Amol D. Kulkarni more than expected).

Fields of papers citing papers by Amol D. Kulkarni

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Amol D. Kulkarni. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Amol D. Kulkarni. The network helps show where Amol D. Kulkarni may publish in the future.

Co-authorship network of co-authors of Amol D. Kulkarni

This figure shows the co-authorship network connecting the top 25 collaborators of Amol D. Kulkarni. A scholar is included among the top collaborators of Amol D. Kulkarni based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Amol D. Kulkarni. Amol D. Kulkarni is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Aziz, Aamir, Arshad M. Khanani, Nikolas London, et al.. (2021). Real World Efficacy and Safety of Brolucizumab in Neovascular AMD: The REBEL Study. Investigative Ophthalmology & Visual Science. 62(8). 451–451. 8 indexed citations
2.
Li, Yifan, Mitchell D. Wolf, Amol D. Kulkarni, et al.. (2020). In Situ Tremor in Vitreoretinal Surgery. Human Factors The Journal of the Human Factors and Ergonomics Society. 63(7). 1169–1181. 1 indexed citations
3.
Martin, Allison N., Amol D. Kulkarni, Rahel Ghebre, et al.. (2019). Cancer Control at the District Hospital Level in Sub-Saharan Africa: An Educational and Resource Needs Assessment of General Practitioners. Journal of Global Oncology. 5(5). 1–8. 8 indexed citations
4.
Bapaye, Amol, et al.. (2015). Peroral endoscopic pyloromyotomy for delayed postoperative gastroparesis. Endoscopy. 47(S 01). E581–E582. 6 indexed citations
5.
6.
Kulkarni, Amol D. & Michael S. Ip. (2012). Diabetic Macular Edema: Therapeutic Options. Diabetes Therapy. 3(1). 1–14. 6 indexed citations
7.
Kulkarni, Amol D., et al.. (2009). Use of combination therapy with cisplatin and calcitriol in the treatment of Y-79 human retinoblastoma xenograft model. British Journal of Ophthalmology. 93(8). 1105–1108. 20 indexed citations
8.
Lucarelli, Mark J., Hee Bae Ahn, Amol D. Kulkarni, & Alon Kahana. (2008). Intratarsal Epidermal Inclusion Cyst. Ophthalmic Plastic and Reconstructive Surgery. 24(5). 357–359. 21 indexed citations
9.
Zacharias, Leandro Cabral, Raja Narayanan, Amol D. Kulkarni, et al.. (2007). Effect of Dexamethasone on Mitochondrial Function and Cell Viability in Human Retinal Pigment Epithelial and Rat Neurosensory Retinal Cells in vitro. Investigative Ophthalmology & Visual Science. 48(13). 2543–2543. 1 indexed citations
10.
Ginkel, Paul R. van, Dhruv Sareen, Lalita Subramanian, et al.. (2007). Resveratrol Inhibits Tumor Growth of Human Neuroblastoma and Mediates Apoptosis by Directly Targeting Mitochondria. Clinical Cancer Research. 13(17). 5162–5169. 155 indexed citations
11.
Chow, Clement C., Amol D. Kulkarni, Daniel M. Albert, Jason K. Darlington, & David R. Hardten. (2007). Clinicopathologic Correlation of Explanted AlphaCor Artificial Cornea After Exposure of Implant. Cornea. 26(8). 1004–1007. 2 indexed citations
12.
Ginkel, Paul R. van, William Yang, Marcus M. Marcet, et al.. (2007). 1 α-Hydroxyvitamin D2 inhibits growth of human neuroblastoma. Journal of Neuro-Oncology. 85(3). 255–262. 15 indexed citations
13.
Kappel, Peter J., Gary N. Holland, Raja Narayanan, et al.. (2006). Outcomes Associated with Ganciclovir Implants in Patients with AIDS-Related Cytomegalovirus Retinitis. Ophthalmology. 113(4). 673–683.e8. 16 indexed citations
14.
Kulkarni, Amol D., et al.. (2005). Effect of Thrombocytopenia on the Progression of Threshold Retinopathy of Prematurity (ROP) After Laser Photocoagulation. Investigative Ophthalmology & Visual Science. 46(13). 4117–4117. 1 indexed citations
15.
Spada, Clayton S., et al.. (2005). Posurdex Inhibits Retinal Vasculopathy and Neuropathy by Intravitreal Vascular Endothelial Growth Factor (VEGF) in Monkeys. Investigative Ophthalmology & Visual Science. 46(13). 3951–3951. 3 indexed citations
16.
Kumar, Atul, et al.. (2005). Vogt-Koyanagi-Harada syndrome with intracranial meningioma: an as yet unreported association. Canadian Journal of Ophthalmology. 40(6). 725–728. 1 indexed citations
17.
Tzekov, Radouil, Ton Lin, Kaiming Zhang, et al.. (2005). Ocular Changes after Photodynamic Therapy. Investigative Ophthalmology & Visual Science. 47(1). 377–377. 71 indexed citations
18.
Orilla, Werhner, et al.. (2004). Diurnal telemetry IOP in rabbits and monkeys: Effect of timolol. Investigative Ophthalmology & Visual Science. 45(13). 2078–2078. 1 indexed citations
19.
Talwar, Dinesh, Amol D. Kulkarni, Rajvardhan Azad, et al.. (2003). Intraocular Ciprofloxacin Levels after Oral Administration in Silicone Oil-Filled Eyes. Investigative Ophthalmology & Visual Science. 44(2). 505–505. 12 indexed citations
20.
Kulkarni, Amol D., et al.. (2001). SILICONE OIL REMOVAL USING VITRECTOMY MACHINE:. Retina. 21(6). 685–687. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Yingjie Ma Breakdown of academic impact, for papers by Dan-dan Zhou Breakdown of academic impact, for papers by Shaopin Zhu Breakdown of academic impact, for papers by Masahiko Kure Breakdown of academic impact, for papers by Fen Xiong Breakdown of academic impact, for papers by Lian Wang Breakdown of academic impact, for papers by Jingxue Ma Breakdown of academic impact, for papers by Giulia Lavinia Fonti Breakdown of academic impact, for papers by Yotaro Matsuoka Breakdown of academic impact, for papers by Peter DeBry
Rankless by CCL
2026